Felypressin acetate
CAS No. 914453-97-7
Felypressin acetate( PLV-2 acetate )
Catalog No. M27820 CAS No. 914453-97-7
Felypressin acetate is an agonist of vasopressin 1 and acts on all arginine vasopressin receptors 1AS. Felypressin acetate can be used in dental procedures.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | Get Quote |
|
| 10MG | 58 | Get Quote |
|
| 25MG | 115 | Get Quote |
|
| 50MG | 177 | Get Quote |
|
| 100MG | 282 | Get Quote |
|
| 200MG | 421 | Get Quote |
|
| 500MG | 678 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameFelypressin acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionFelypressin acetate is an agonist of vasopressin 1 and acts on all arginine vasopressin receptors 1AS. Felypressin acetate can be used in dental procedures.
-
DescriptionFelypressin acetate is an agonist of vasopressin 1 and acts on all arginine vasopressin receptors 1AS. Felypressin acetate can be used in dental procedures.(In Vitro):Felypressin is a synthetic hormone of the posterior pituitary lobe characterized by vasoconstrictor properties mediated by V1 receptors of the blood vessel smooth muscle cells.(In Vivo):In Wistar rats, Felypressin (240 ng/kg; i.v.) induces a pressor effect and bradycardic effect depending on V1 receptors to induce pressor and bradycardic effects. Felypressin produces a high relationship between bradycardia and mean arterial pressure variation depending on area postrema and central V1 receptors. Felypressin reduces toxicity during dental procedures. Felypressin increases the diastolic blood pressure of hypertensive patients with controlled blood pressure.
-
In VitroFelypressin is a synthetic hormone of the posterior pituitary lobe characterized by vasoconstrictor properties that is widely used in dental procedures. The vasoconstrictor action of Felypressin seems to be mediated by V1 receptors of the blood vessel smooth muscle cells.
-
In VivoFelypressin can reduce toxicity during dental procedures. Felypressin increases the diastolic blood pressure of hypertensive patients with controlled blood pressure. Cardiovascular effects of Felypressin (240 ng/kg; intravenous injection) are studied in Wistar rats. Felypressin induces a pressor effect. Felypressin depends on V1 receptors to induce pressor and bradycardic effects, and that it produces a high relationship between bradycardia and mean arterial pressure variation depending on area postrema and central V1 receptors.
-
SynonymsPLV-2 acetate
-
PathwayGPCR/G Protein
-
TargetVasopressin Receptor
-
RecptorMEK1|MEK2|Autophagy|Mitophagy
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number914453-97-7
-
Formula Weight1100.28
-
Molecular FormulaC48H69N13O13S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL
-
SMILESCC(O)=O.NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bessard A, et al. RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo. Oncogene. 2008 Sep 11;27(40):5315-25.
molnova catalog
related products
-
TASP0390325
TASP0390325 is an orally active and high affinity arginine pressin receptor 1B (V1B receptor) antagonist that shows antidepressant and anxiolytic activity in animal studies and blocks V1B receptors in the anterior pituitary gland in vivo.
-
Lixivaptan
Lixivaptan is an orally active and selective vasopressin receptor V2 antagonist(Ki = 2.3 nM).
-
d[Cha4]-AVP
Potent and selective human vasopressin V1B receptor agonist (Ki values are 1.2, 151, 240 and 750 nM for V1B, V1A, Oxytocin and V2 receptors respectively). Stimulates ACTH and corticosterone secretion and exhibits negligible vasopressor activity in vivo.
Cart
sales@molnova.com